Document is current

Article History

Received: 5 March 2020

Revised: 27 August 2020

Accepted: 2 September 2020

First Online: 21 September 2020

Compliance with ethical standards

:

: All authors received research funding from Celgene Co., Ono Pharmaceutical. CS received honoraria from Fujimoto Pharmaceutical Co. HT, HS, MH, AT, IM, KI received honoraria from Novartis Pharmaceuticals Co. JKU, HS, AT received honoraria from Janssen Pharmaceuticals. JKU, AT, IM, KI received honoraria from Bristol-Myers Squibb. JKU, HS, IM, KI received honoraria from Takeda Pharmaceutical Co. HS, KI received honoraria from Kyowa Hakko Kirin Co. HS, KI received honoraria from Chugai Pharmaceutical Co. MH, IM received honoraria from Pfizer, Inc. MH received honoraria from Merck & Co. IM received honoraria from AbbVie GK. KI received honoraria from Nippon Shinyaku, Otsuka Pharmaceutical Co, Sumitomo Dainippon Pharma, Astellas Pharma, Shire Japan. JKU, AT received research funding from Bristol-Myers Squibb. JKU received research funding from Sysmex Co. AT received research funding from COGNANO Co, Sumitomo Dainippon Pharma, Thyas Co. IM, YK received research funding from Chugai Pharmaceutical Co. IM received research funding from Pfizer, Inc, Eisai Co., Merck & Co., Nippon Shinyaku, Otsuka Pharmaceutical Co., Mundipharma K.K. YK received research funding from Alexion Pharma. HS received research funding from Takeda Pharmaceutical Co., Janssen Pharmaceuticals, Novartis Pharmaceuticals Co., Sanofi K.K., AstraZeneca K.K., AbbVie GK., IQVIA Services Japan K.K